Browse > Article

Inhibitory Effect of Panax notoginseng on Nitric Oxide Synthase, Cyclo-oxygenase-2 and Neutrophil Functions  

Park, Soon-Gi (Department of AM-Pointology, Diagnostics and Cardiovascular Medical Research Center)
Joo, Shin-Tak (Department of AM-Pointology, Diagnostics and Cardiovascular Medical Research Center)
Ban, Chang-Gyu (Department of AM-Pointology, Diagnostics and Cardiovascular Medical Research Center)
Moon, Jin-Young (Department of AM-Pointology, Diagnostics and Cardiovascular Medical Research Center)
Park, Sun-Dong (Department of Prescription, College of Korean Medicne, Dongguk University)
Park, Won-Hwan (Department of AM-Pointology, Diagnostics and Cardiovascular Medical Research Center)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.20, no.5, 2006 , pp. 1295-1302 More about this Journal
Abstract
Our preliminary aim is to elucidate the pharmacokinetic features of the PNS(Panax notoginseng Buck F.H. Chen. (Arialiaceae) root). First, we assessed the prevention of neurtrophil functions. A Panax notoginseng inhibited neutrophil functions, including degranulation, superoxide generation, and leukotriene B4 production, without any effect on 5-lipoxygenase activity. This Panax notoginseng reduced nitric oxide (NO) and prostaglandin E2 production in mouse peritoneal macrophages stimulated with lipopolysaccharide, whereas no influence on the activity of inducible NO synthase, cyclo-oxygenase-2 or cyclo-oxygenase-1 was observed. Panax notoginseng significantly reduced mouse paw oedema induced by carrageenan. The results indicate that Panax notoginseng exerts anti-inflammatory effects related to the inhibition of neutrophil functions and of NO and prostaglandin E2 production, which could be due to a decreased expression of inducible NO synthase and cyclo-oxygenase-2.
Keywords
PNS(Panax notoginseng); neurtrophil functions; nitric oxide (NO); prostaglandin E2; cyclo-oxygenase-2;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wu, M.Z., Yunnan Chih Wu Ten Chiu 1:119-124, 1979
2 Zhou, J., Wu, M.Z., Taniyasu, S., Besso, H., Tanaka, O., Saruwatari, Y., Fuwa, T. Chem. Pharm. Bull. 29:2844-2850, 1981   DOI
3 Matsuura, H., Kasai, R., Tanaka, O., Saruwatari, Y., Fuwa, T., Zhou, J. Chem. Pharm. Bull. 31:2281-2287, 1983   DOI
4 Yamaguchi, H., Kasai, R., Matsuura, H., Tanaka, O., Fuwa, T. Chem. Pherm. Bull. 36:3468-3473, 1988   DOI   ScienceOn
5 Ma, L.Y., Xiao, P.G., Liang, F.Q. and Wu, J.H. Protective effects of Panax notoginseng saponins on primary cortical cultures of rat. Chinese Pharmaceutical Journal 333:143-144, 1998
6 Han, J.A., Hu, W.Y. and Sun, Z.H. Effect of Panax notoginseng Saponin on $Ca^{2+}$, CaM in craniocerebral injury. Chinese Journal of Integrated Traditional and Western Medicine 194:227-229, 1999
7 Hasegawa, H., Lee, K.S., Nagaoka, T., Tezuka, Y., Uchiyama, M., Kadota, S. and Saiki, I. Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters. Biological and Pharmaceutical Bulletin 233:298-304, 2000
8 Smith, J.A. Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukocyte Biol. 56, MEDLINE Abstract EMBASE pp 672-686, 1994   DOI
9 Escrig, V., Ubeda, A., Ferrandiz, M.L., Darias, J., Sanchez, J.M., Alcaraz, M.J. and Paya, M. Variabilin: a dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity. J. Pharmacol. Exp. Ther. 282:123-131, 1997
10 Mitchell, J.A., Sheng, H., Forstermann, U. and Murad, F. Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle. Br. J. Pharmacol. 104:289-291, 1991   DOI   ScienceOn
11 Ianaro, A., O'Donnell, C.A., Di Rosa, M. and Liew, F.Y. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology 82:370-37, 1994
12 Zhu, X.X., Mao, Y.W., He, R.X., Yamamoto, A. and Shoyama, Y. Determination of ginsenosides in Panax genseng by HPLC. Chin. J. Biochem. Pharmaceutics 191:28-30, 1998
13 Remick, D.G. and Villarete, L. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates. J. Leukocyte Biol. 59:471-475, 1996   DOI
14 Brownlie, R.P., Brownrigg, N.J., Butcher, H.M., Garcia, R., Jessup, R., Lee, V.J., Tunstall, S. and Wayne, M.G. ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro. Br. J. Pharmacol. 110:1600-1606, 1993   DOI   ScienceOn
15 Salvemini, D., Wang, Z.Q., Bourdon, D.M., Stern, M.K., Currie, M.G. and Manning, P.T. Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur. J. Pharmacol. 303:217-220, 1996   DOI   ScienceOn
16 Li, X.H. and Li, S.H. Effects of total saponins of Sanchi (Panax pseudo-ginseng notoginseng) on TNF, NO and its mechanisms. Chinese Traditional and Herbal Drugs 307:514-517, 1999
17 Yang, T.R., Kasai, R., Zhou, J., Tanaka, O. Phytochemistry 22:1473-1478, 1983   DOI   ScienceOn
18 Sanada, S., Shoji, J. Shoyakugaku Zasshi, 32:96-99, 1978
19 Tateson, J.E., Randall, R.W., Reynolds, C.H., Jackson, W.P., Bhattacherjee, P., Salmon, J.A. and Garland, L.G. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br. J. Pharmacol. 94:528-539, 1988   DOI   ScienceOn
20 Kang, R.Y., Freire Moar, J., Sigal, E. and Chu, C.Q. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br. J. Rheumatol. 35:711-718, 1996   DOI
21 Taniyasu, S., Tanaka, O., Yang, T.R., Zhou, J. Planta Med. 44:124-125, 1982   DOI
22 Henderson, W.R. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:684-697, 1994   DOI   ScienceOn
23 Yoshikawa, M., Morikawa, T., Yashiro, K., Murakami, T., Matsuda, H. Chem. Pharm. Bull. 49:1452-1456, 2001   DOI   ScienceOn
24 Wei, C.H., Wang. C.F., Chang, L.Y., Tu, Y.C. Yao Hsueh Tung Dao 15:43-44, 1980
25 Zhang, G.Q., Ye, R.G., Kong, Q.Y., Yang, N.S., Zhang, J.L., Guan, W.M. and Chen, Y.X. Panax notoginseng saponins induced of human renal interstitial fibroblasts and its mechanisms. Chinese Journal of Nephrology 14(2):93-95, 1998
26 Bustos, G., Ferrandiz, M.L., Sanz, M.J., Paya, M. and Alcaraz, M.J. A study of the novel anti-inflammatory agent florifenine. Topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:298-304, 1995
27 Moroney, M.A., Alcaraz, M.J., Forder, R.A., Carey, F. and Hoult, J.R.S. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J. Pharm. Pharmacol. 40:787-792, 1988   DOI
28 Misko, T.P., Schilling, R.J., Salvemini, D., Moore, W.M. and Currie, M.G. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214:11-16, 1993   DOI   ScienceOn
29 Cicero, A.F.G., Bandieri, E. and Arletti, R. Orally administered Panax notoginseng influence on rat spontaneous behavior. Journal of Ethnopharmacology 73:387-391, 2000   DOI   ScienceOn
30 Shen, Y.J. Pharmacology of Traditional Chinese Medicine, Renmin Weisheng Press, Beijing, China. 2000
31 Namba, T., Matsushige, K., Morita, T., Tanaka, O. Chem. Pharm. Bull. 34:736-738, 1986
32 MacMicking, J., Xie, Q.W. and Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350, 1997   DOI   ScienceOn
33 Ahn, J.C. A korean herbal medicine, Panax notoginseng, prevents liver fibrosis in LEC rats and gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats. The Journal Of The Korean Institute Of Oriental Medical Diagnostics. 2003
34 Sugishita, E., Amagaya, S. and Ogihara, Y. Anti- inflammatory testing methods: comparative evaluation of mice and rats. J. Pharmacobio-Dyn. 4:565-575, 1981   DOI
35 Ma, L.Y. and Xiao, P.G. Effects of saponins of Panax notoginseng on intracellular free $Ca^{2+}$ concentration in dissociated neurons. Chinese Pharmaceutical Journal 338:467-469, 1998
36 Marcinkiewicz, J., Grabowska, A. and Chain, B. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25:947-951, 1995   DOI   ScienceOn
37 Gross, S.S. and Levi, R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem. 267:25722-2572, 1992
38 Fujiwara, K., Ohta, Y., Ogata, I. Treatment trial of traditional oriental medicine in chronic viral hepatitis. In: Ohta Y, ed. New Trends in Peptic Ulcer and Chronic Hepatitis. Part II Chronic Hepatitis. Tokyo: Excerpta Medica, pp 141-146, 1987
39 Li, X.C. Chinese herbal study on anti-ischemia-reperfusion- injury. Chinese Journal of Hospital Pharmacy 154:1-4, 1998
40 Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L. and Isakson, P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A. 91:12013-12017, 1994